Synergistic effects of MAPK and immune checkpoint inhibitors in melanoma: what is the best combination strategy?

被引：1

作者：

Wilmott, James S. ^{[1
,2
]}

Hersey, Peter ^{[1
,2
]}

Long, Georgina V. ^{[1
,2
]}

Scolyer, Richard A. ^{[1
,2
,3
]}

机构：

[1] Melanoma Inst Australia, Sydney, NSW, Australia

[2] Univ Sydney, Sydney, NSW, Australia

[3] Royal Prince Alfred Hosp, Tissue Pathol Diagnost Oncol, Camperdown, NSW 2050, Australia

来源：

MELANOMA MANAGEMENT | 2015年 / 2卷 / 01期

关键词：

BRAF; chemokine; immune response; immunotherapy; melanoma; PD1; targeted therapy; tumor infiltrating lymphocytes; tumor microenvironment;

D O I：

10.2217/MMT.14.26

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：15 / 19

页数：5

共 24 条

[1] Outcomes of Patients With Metastatic Melanoma Treated With Immunotherapy Prior to or After BRAF Inhibitors [J].

Ackerman, Allison ;

Klein, Oliver ;

McDermott, David F. ;

Wang, Wei ;

Ibrahim, Nageatte ;

Lawrence, Donald P. ;

Gunturi, Anasuya ;

Flaherty, Keith T. ;

Hodi, F. Stephen ;

Kefford, Richard ;

Menzies, Alexander M. ;

Atkins, Michael B. ;

Long, Georgina V. ;

Sullivan, Ryan J. .

CANCER, 2014, 120 (11) :1695-1701

[2] Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma [J].

Ascierto, Paolo A. ;

Minor, David ;

Ribas, Antoni ;

Lebbe, Celeste ;

O'Hagan, Anne ;

Arya, Niki ;

Guckert, Mary ;

Schadendorf, Dirk ;

Kefford, Richard F. ;

Grob, Jean-Jacques ;

Hamid, Omid ;

Amaravadi, Ravi ;

Simeone, Ester ;

Wilhelm, Tabea ;

Kim, Kevin B. ;

Long, Georgina V. ;

Martin, Anne-Marie ;

Mazumdar, Jolly ;

Goodman, Vicki L. ;

Trefzer, Uwe .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26) :3205-+

[3] Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use [J].

Ascierto, Paolo A. ;

Simeone, Ester ;

Giannarelli, Diana ;

Grimaldi, Antonio M. ;

Romano, Anna ;

Mozzillo, Nicola .

JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10

[4] Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma [J].

Atefi, Mohammad ;

Avramis, Earl ;

Lassen, Amanda ;

Wong, Deborah J. L. ;

Robert, Lidia ;

Foulad, David ;

Cerniglia, Michael ;

Titz, Bjoern ;

Chodon, Thinle ;

Graeber, Thomas G. ;

Comin-Anduix, Begonya ;

Ribas, Antoni .

CLINICAL CANCER RESEARCH, 2014, 20 (13) :3446-3457

[5] Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function [J].

Boni, Andrea ;

Cogdill, Alexandria P. ;

Dang, Ping ;

Udayakumar, Durga ;

Njauw, Ching-Ni Jenny ;

Sloss, Callum M. ;

Ferrone, Cristina R. ;

Flaherty, Keith T. ;

Lawrence, Donald P. ;

Fisher, David E. ;

Tsao, Hensin ;

Wargo, Jennifer A. .

CANCER RESEARCH, 2010, 70 (13) :5213-5219

[6] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].

Chapman, Paul B. ;

Hauschild, Axel ;

Robert, Caroline ;

Haanen, John B. ;

Ascierto, Paolo ;

Larkin, James ;

Dummer, Reinhard ;

Garbe, Claus ;

Testori, Alessandro ;

Maio, Michele ;

Hogg, David ;

Lorigan, Paul ;

Lebbe, Celeste ;

Jouary, Thomas ;

Schadendorf, Dirk ;

Ribas, Antoni ;

O'Day, Steven J. ;

Sosman, Jeffrey A. ;

Kirkwood, John M. ;

Eggermont, Alexander M. M. ;

Dreno, Brigitte ;

Nolop, Keith ;

Li, Jiang ;

Nelson, Betty ;

Hou, Jeannie ;

Lee, Richard J. ;

Flaherty, Keith T. ;

McArthur, Grant A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516

[7] Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade [J].

Cooper, Zachary A. ;

Juneja, Vikram R. ;

Sage, Peter T. ;

Frederick, Dennie T. ;

Piris, Adriano ;

Mitra, Devarati ;

Lo, Jennifer A. ;

Hodi, Stephen ;

Freeman, Gordon J. ;

Bosenberg, Marcus W. ;

McMahon, Martin ;

Flaherty, Keith T. ;

Fisher, David E. ;

Sharpe, Arlene H. ;

Wargo, Jennifer A. .

CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) :643-654

[8] BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma [J].

Frederick, Dennie T. ;

Piris, Adriano ;

Cogdill, Alexandria P. ;

Cooper, Zachary A. ;

Lezcano, Cecilia ;

Ferrone, Cristina R. ;

Mitra, Devarati ;

Boni, Andrea ;

Newton, Lindsay P. ;

Liu, Chengwen ;

Peng, Weiyi ;

Sullivan, Ryan J. ;

Lawrence, Donald P. ;

Hodi, F. Stephen ;

Overwijk, Willem W. ;

Lizee, Gregory ;

Murphy, George F. ;

Hwu, Patrick ;

Flaherty, Keith T. ;

Fisher, David E. ;

Wargo, Jennifer A. .

CLINICAL CANCER RESEARCH, 2013, 19 (05) :1225-1231

[9]

Hauschild A, 2012, J CLIN ONCOL, DOI [10.1158/1078-0432.CCR-13-0779, DOI 10.1158/1078-0432.CCR-13-0779]

[10] Long-term survival of ipilimumab-naive patients (pts) with advanced melanoma (MEL) treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) in a phase I trial. [J].

Hodi, F. Stephen ;

Sznol, Mario ;

Kluger, Harriet M. ;

McDermott, David F. ;

Carvajal, Richard D. ;

Lawrence, Donald P. ;

Topalian, Suzanne Louise ;

Atkins, Michael B. ;

Powderly, John D. ;

Sharfman, William Howard ;

Puzanov, Igor ;

Smith, David C. ;

Leming, Philip D. ;

Lipson, Evan J. ;

Taube, Janis M. ;

Anders, Robert ;

Horak, Christine E. ;

Kollia, Georgia ;

Gupta, Ashok Kumar ;

Sosman, Jeffrey Alan .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

← 1 2 3 →